Skip to main content
Skip to content
Case File
efta-efta00850135DOJ Data Set 9Other

From: Elie Kobrin

Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00850135
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Elie Kobrin To: 'Jeffrey L Port' <1 jeffrey E. <jeevacation®gmail.com> Subject: RE: How much is a biotech with no approved drugs worth? Billions, NantKwest investors say Date: Wed, 29 Jul 2015 13:34:39 +0000 Yup, wild. Yesterday it basically had the same enterprise value as JUNO. From: Jeffrey L Port (mallto: Sent: Wednesday, July 29, 2015 9:31 AM To: Die Kobrin; Jeffrey E. Subject: How much is a biotech with no approved drugs worth? Billions, NantKwest investors say A cell therapy company founded by a surgeon who is a serial entrepreneur Here is something from WSJ.com that might interest you: How much is a biotech with no approved drugs worth? Billions, NantKwest investors say http://on.wsj.com/I.LPOiClA This communication is intended only for the addressee(s) and may contain confidential information. We do not waive any confidentiality by misdelivery. If you receive this communication in error, any use, dissemination, printing or copying is strictly prohibited; please destroy all electronic and paper copies and notify the sender immediately. EFTA00850135

Technical Artifacts (2)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Domaingmail.com
URLhttp://on.wsj.com/I.LPOiClA

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.